Shalby Limited (NSE:SHALBY)
India · Delayed Price · Currency is INR 171.20
-0.53 (-0.31%)
Jan 23, 2026, 10:25 AM IST
Shalby Market Cap
Shalby has a market cap or net worth of 18.45 billion as of January 22, 2026. Its market cap has decreased by -27.86% in one year.
Market Cap
18.45B
Enterprise Value
23.61B
Revenue
11.22B
Ranking
n/a
PE Ratio
412.02
Stock Price
171.20
Market Cap Chart
Since December 15, 2017, Shalby's market cap has decreased from 25.88B to 18.45B, a decrease of -28.72%. That is a compound annual growth rate of -4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 18.45B | -15.79% |
| Dec 31, 2025 | 21.90B | -11.24% |
| Dec 31, 2024 | 24.68B | -24.00% |
| Dec 29, 2023 | 32.47B | 100.73% |
| Dec 30, 2022 | 16.18B | 6.26% |
| Dec 31, 2021 | 15.22B | 29.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.02T |
| Divi's Laboratories | 1.63T |
| Cipla | 1.12T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 886.59B |
| Mankind Pharma | 873.99B |
| Alkem Laboratories | 687.26B |
| Aurobindo Pharma | 678.14B |